References
- The Korean Pediatric Society. Pneumococcal vaccine. In: Lee HJ, editor. Immunization Guideline. 6th ed. Seoul: The Korean Pediatric Society, 2008;196-216.
- Dagan R, Jacobs MR, Greenberg D. Pneumococcal infections. In: Feigin RD, Cherry JD, Demmler GJ, Kaplan S, editors. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia: WB Saunders, 2004;1204-58.
- Lee JH, Cho HK, Kim KH, Kim CH, Kim DS, Kim KN, et al. Etiology of invasive bacterial infections in immunocompetent children in Korea (1996-2005): A retrospective multicenter study. J Korean Med Sci 2011;26:174-83. https://doi.org/10.3346/jkms.2011.26.2.174
- Kim SH, Song EK, Lee JH, Kim NH, Lee JA, Choi EH, et al. Changes of serotype distribution of Streptococcus pneumoniae isolated from children in Korea over a 15 year-period (1991-2005). Korean J Pediatr Infect Dis 2006;13:89-98.
- Lee TJ, Chun JK, Choi KM, Yong DE, Lee KW, Kim DS. Trends in serotype distribution of clinical isolates of Streptococcus pneumoniae : a single center experience from 2001 to 2006. Korean J Pediatr Infect Dis 2006;13:115-23.
- Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee HJ, et al. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 2008;14:275-81. https://doi.org/10.3201/eid1402.070807
- Korean Centers for Disease Control and Prevention. Serotype distribution and antimicrobial susceptibility of invasive Streptococcus pneumoniae clinical isolates in Korea. Public Health Wkly Rep 2010;3:1-7.
- World Health Organization. Technical Report Series, No. 927, Annex 2. Recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines, 2009.
- Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsene JP, et al. Immunogenicity of the 10-Valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) vompared to the licensed 7vCRM vaccine. Pediatr Infect Dis J 2009;28(4 Suppl):S66-S76.
- Food and Drug Administration. Prevnar 13: clinical review of new product license application. Rockville, MD: Food and Drug Administration, 2010.
- Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and nontypeable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006;367:740-8. https://doi.org/10.1016/S0140-6736(06)68304-9
- Centers for Disease Control and Prevention. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children-Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2010;59:258-61.
- Nuorti JP, Whitney CG;Centers for Disease Control and Prevention. Prevention of pneumococcal disease among infants and children-Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine. MMWR Morb Mortal Wkly Rep 2010;59(RR-11):1-18.
Cited by
- Cross-reaction of 6B and 19F Specific Antibodies to Serotypes 6A, 6C, and 19A after Immunization with 7-valent Pneumococcal Conjugate Vaccine in Korean Children Aged 12-23 Months vol.20, pp.2, 2011, https://doi.org/10.14776/kjpid.2013.20.2.53
- The Association between Asthma and Invasive Pneumococcal Disease: A Nationwide Study in Korea vol.30, pp.1, 2011, https://doi.org/10.3346/jkms.2015.30.1.60
- Changes in pneumococcal nasopharyngeal colonization among children with respiratory tract infections before and after use of the two new extended-valency pneumococcal conjugated vaccines vol.47, pp.6, 2011, https://doi.org/10.3109/00365548.2014.1001997
- Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea vol.14, pp.1, 2011, https://doi.org/10.1080/21645515.2017.1362513
- A 6-year safety surveillance of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in South Korea vol.14, pp.12, 2011, https://doi.org/10.1080/21645515.2018.1502525
- Why are people with asthma susceptible to pneumonia? A review of factors related to upper airway bacteria vol.24, pp.5, 2011, https://doi.org/10.1111/resp.13528
- Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation vol.18, pp.6, 2011, https://doi.org/10.1080/14760584.2019.1627207
- The Analysis of Scientific Data on the Efficacy of Pneumococcal Conjugated Vaccine in the Cohort of Children with Bronchial Asthma vol.17, pp.5, 2011, https://doi.org/10.15690/pf.v17i5.2187